MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
FBIO — Fortress Biotech, Inc.
NasdaqFortress Biotech, Inc.
$2.03
-0.04(-1.93%)
- O
- 2.08
- H
- 2.09
- L
- 2.01
- V
- 325.79K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About FBIO
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 17, 2011
Employees78
Stock ExchangeNasdaq
Ticker SymbolFBIO
Key Financial Statistics
| Market Cap | $67.70M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.01 - $4.53 |
| 52-Week Avg Volume | 605.8K |
| VWAP | $2.03 |
| Transactions | 2,239 |
| Total Recorded Bars | 3,739 days |